130 related articles for article (PubMed ID: 23831323)
21. Combination of a T cell activating therapy and anti-phosphatidylserine enhances anti-tumour immune responses in a HPV16 E7-expressing C3 tumour model.
Dirk BS; Weir G; Quinton T; Hrytsenko O; Stanford MM
Sci Rep; 2021 Feb; 11(1):4502. PubMed ID: 33627686
[TBL] [Abstract][Full Text] [Related]
22. Different serotypes of Escherichia coli flagellin exert identical adjuvant effects.
Pang S; Wu W; Liu Q; Zhu G; Duan Q
BMC Vet Res; 2022 Aug; 18(1):308. PubMed ID: 35953794
[TBL] [Abstract][Full Text] [Related]
23. Preclinical evaluation of two phylogenetically distant arenavirus vectors for the development of novel immunotherapeutic combination strategies for cancer treatment.
Raguz J; Pinto C; Pölzlbauer T; Habbeddine M; Rosskopf S; Strauß J; Just V; Schmidt S; Bidet Huang K; Stemeseder F; Schippers T; Stewart E; Jez J; Berraondo P; Orlinger KK; Lauterbach H
J Immunother Cancer; 2024 Apr; 12(4):. PubMed ID: 38631709
[TBL] [Abstract][Full Text] [Related]
24. Delayed vaccine-induced CD8
van der Sluis TC; van Haften FJ; van Duikeren S; Pardieck IN; de Graaf JF; Vleeshouwers W; van der Maaden K; Melief CJM; van der Burg SH; Arens R
J Immunother Cancer; 2023 Nov; 11(11):. PubMed ID: 38030302
[TBL] [Abstract][Full Text] [Related]
25. Vaccine nanodiscs plus polyICLC elicit robust CD8+ T cell responses in mice and non-human primates.
Najafabadi AH; Abadi ZIN; Aikins ME; Foulds KE; Donaldson MM; Yuan W; Okeke EB; Nam J; Xu Y; Weerappuli P; Hetrick T; Adams D; Lester PA; Salazar AM; Barouch DH; Schwendeman A; Seder RA; Moon JJ
J Control Release; 2021 Sep; 337():168-178. PubMed ID: 34280415
[TBL] [Abstract][Full Text] [Related]
26. Luteolin as an adjuvant effectively enhances CTL anti-tumor response in B16F10 mouse model.
Tian L; Wang S; Jiang S; Liu Z; Wan X; Yang C; Zhang L; Zheng Z; Wang B; Li L
Int Immunopharmacol; 2021 May; 94():107441. PubMed ID: 33611060
[TBL] [Abstract][Full Text] [Related]
27. Engineering
Zhang H; Luo Y; Zhao X; Liu X
Mol Ther Oncol; 2024 Mar; 32(1):200770. PubMed ID: 38596299
[TBL] [Abstract][Full Text] [Related]
28. TLR5 agonist in combination with anti-PD-1 treatment enhances anti-tumor effect through M1/M2 macrophage polarization shift and CD8
Lee J; Im KI; Gil S; Na H; Min GJ; Kim N; Cho SG
Cancer Immunol Immunother; 2024 Apr; 73(6):102. PubMed ID: 38630304
[TBL] [Abstract][Full Text] [Related]
29.
Wang S; Cheng M; Chen CC; Chang CY; Tsai YC; Yang JM; Wu TC; Huang CH; Hung CF
Oncoimmunology; 2024; 13(1):2298444. PubMed ID: 38170154
[TBL] [Abstract][Full Text] [Related]
30. Efficacy of LCMV-based cancer immunotherapies is unleashed by intratumoral injections of polyI:C.
Gomar C; Di Trani CA; Bella A; Arrizabalaga L; Gonzalez-Gomariz J; Fernandez-Sendin M; Alvarez M; Russo-Cabrera JS; Ardaiz N; Aranda F; Schippers T; Quintero M; Melero I; Orlinger KK; Lauterbach H; Berraondo P
J Immunother Cancer; 2024 Apr; 12(4):. PubMed ID: 38631714
[TBL] [Abstract][Full Text] [Related]
31. Construction of the flagellin F mutant of Vibrio parahaemolyticus and its toxic effects on silver pomfret (Pampus argenteus) cells.
Li Y; Liu C; Sun Y; Wang R; Wu C; Zhao H; Zhang L; Song D; Gao Q
Int J Biol Macromol; 2024 Feb; 259(Pt 2):129395. PubMed ID: 38218285
[TBL] [Abstract][Full Text] [Related]
32. Advantages and Limitations of Integrated Flagellin Adjuvants for HIV-Based Nanoparticle B-Cell Vaccines.
Barnowski C; Kadzioch N; Damm D; Yan H; Temchura V
Pharmaceutics; 2019 May; 11(5):. PubMed ID: 31052410
[TBL] [Abstract][Full Text] [Related]
33. Intramuscular vaccination targeting mucosal tumor draining lymph node enhances integrins-mediated CD8+ T cell infiltration to control mucosal tumor growth.
Qiu J; Peng S; Yang A; Ma Y; Han L; Cheng MA; Farmer E; Hung CF; Wu TC
Oncoimmunology; 2018; 7(8):e1463946. PubMed ID: 30221059
[No Abstract] [Full Text] [Related]
34. Robust anti-tumor T cell response with efficient intratumoral infiltration by nanodisc cancer immunotherapy.
Kuai R; Singh PB; Sun X; Xu C; Najafabadi AH; Scheetz L; Yuan W; Xu Y; Hong H; Keskin DB; Wu CJ; Jain R; Schwendeman A; Moon JJ
Adv Ther (Weinh); 2020 Sep; 3(9):. PubMed ID: 38317797
[TBL] [Abstract][Full Text] [Related]
35. A microbial-based cancer vaccine for induction of EGFRvIII-specific CD8+ T cells and anti-tumor immunity.
Zebertavage L; Bambina S; Shugart J; Alice A; Zens KD; Lauer P; Hanson B; Gough MJ; Crittenden MR; Bahjat KS
PLoS One; 2019; 14(1):e0209153. PubMed ID: 30601871
[TBL] [Abstract][Full Text] [Related]
36. Mucosal TLR5 activation controls healthspan and longevity.
Lim JS; Jeon EJ; Go HS; Kim HJ; Kim KY; Nguyen TQT; Lee DY; Kim KS; Pietrocola F; Hong SH; Lee SE; Kim KS; Park TS; Choi DH; Jeong YJ; Park JH; Kim HS; Min JJ; Kim YS; Park JT; Cho JH; Lee GW; Lee JH; Choy HE; Park SC; Lee CH; Rhee JH; Serrano M; Cho KA
Nat Commun; 2024 Jan; 15(1):46. PubMed ID: 38167804
[TBL] [Abstract][Full Text] [Related]
37. Deglycosylation of eukaryotic-expressed flagellin restores adjuvanticity.
Khim K; Puth S; Radhakrishnan K; Nguyen TD; Lee YS; Jung CH; Lee SE; Rhee JH
NPJ Vaccines; 2023 Sep; 8(1):139. PubMed ID: 37752138
[TBL] [Abstract][Full Text] [Related]
38. Structure and biological activity in vitro of Flagellin and its mutants from Escherichia coli Nissle 1917.
Li S; Wen M; Wen G; Yang Y
Arch Microbiol; 2024 Apr; 206(5):221. PubMed ID: 38637410
[TBL] [Abstract][Full Text] [Related]
39. Proteomimetic Polymers Trigger Potent Antigen-Specific T Cell Responses to Limit Tumor Growth.
Wang MM; Choi MR; Battistella C; Gattis B; Qiao B; Evangelopoulos M; Mirkin CA; Olvera de la Cruz M; Zhang B; Gianneschi NC
J Am Chem Soc; 2024 May; ():. PubMed ID: 38781575
[TBL] [Abstract][Full Text] [Related]
40. The sound of silence.
Clasen S
Science; 2023 Jul; 381(6653):37-38. PubMed ID: 37410824
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
